[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:oncogenic-mutation-alteration":3},{"name":4,"total":5,"recruiting":5,"trials":6},"oncogenic mutation\u002Falteration",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06564623","Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)",[11],"Phase 1","RECRUITING","2026-08-26T02:19:27.519777Z","2026-05-05T02:43:27.336458Z"]